Sir Bradley Wiggins set for final appearance on British soil

The 36-year-old, under scrutiny after seeking permission to use triamcinolone before three of his biggest races, will compete in next week's London Six Day competition with Mark Cavendish.

Wiggins has long planned to ride in the October 25 to 30 competition at the Lee Valley VeloPark, where he and Cavendish won the Madison world title in March.

The five-time Olympic champion's final event is scheduled to be November's 15 to 20 Ghent Six Day - unless Wiggins opts against retirement and decides to ride on in 2017.

Wiggins was born in the Belgian city and finishing with the Ghent competition would see his career come full circle.

Wiggins' participation in London was confirmed on the day the Abu Dhabi Tour, in which Cavendish is racing, announced its starters.

Wiggins angered the race organisers by not competing, having been used in publicity material under "good faith". His eponymous team is competing in the four-day race which begins on Thursday.

Wiggins became the Briton with the most Olympic medals in August, but his career, which includes becoming Britain's first Tour de France champion in 2012, is in danger of ending on a sour note.

Data stolen by hackers from files held by the World Anti-Doping Agency showed Wiggins received three therapeutic use exemptions (TUEs) for anti-inflammatory drug triamcinolone - a substance which has a history of abuse in cycling and is otherwise banned - on the eve of the 2011 and 2012 Tours and 2013 Giro d'Italia.

Wiggins and Team Sky principal Sir Dave Brailsford, the British Cycling performance director until April 2014, have strenuously denied any wrongdoing, insisting each time the TUEs were medically necessary to deal with a pollen allergy that aggravates Wiggins' long-standing asthma condition.

The TUEs also had the approval of the UCI, cycling's world governing body, and there is no suggestion that Wiggins, who left Team Sky in April 2015, or the team, have broken any rules.